An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic stimulation, and digital ...

Hope Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced engagement of BTIG, a leading global financial services firm specializing in investment banking, institutional ...

NRx Pharmaceuticals (NRXP) announced that it has entered into a binding agreement for a registered direct offering of its common stock with ...

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal ...

NRx Pharmaceuticals, Inc. recently disclosed its ... of HOPE’s Series A Preferred Stock convertible into one-third of all fully diluted outstanding equity of HOPE, along with 730,000 shares ...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a Delaware-based pharmaceutical company with a market capitalization of $61.63 million, announced the immediate resignation of Janet Rehnquist from its ...

Complete access to all Tablet website content including all premium content. Access to the weekly digital copy of The Tablet. Full access to The Tablet’s archive – over 180 years of back issues.

Complete access to all Tablet website content including all premium content. Access to the weekly digital copy of The Tablet. Full access to The Tablet’s archive – over 180 years of back issues.